Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple bacterial macromolecules is a collective term used to describe the diverse array of essential cellular components—including proteins, nucleic acids, and lipids—that are targeted by broad-spectrum antimicrobial agents (DrugBank, DB06812). This target designation is typically used for antiseptics and disinfectants that do not bind to a single specific receptor or enzyme but instead exert their effects through rapid, multi-site chemical reactions such as oxidation, alkylation, or denaturation (StatPearls, "Antiseptics and Disinfectants"). By simultaneously damaging various structural and functional molecules, these agents disrupt vital processes including cell wall integrity, metabolic pathways, and genetic replication, leading to rapid cell death (PubMed, PMID: 15479116). This multi-target approach is highly effective against a wide spectrum of pathogens and significantly reduces the likelihood of resistance development, as it would require multiple simultaneous mutations to bypass the damage (NIH, "Mechanism of Action of Microbicides"). However, the inherent lack of selectivity means these agents can also damage host tissues, which generally restricts their clinical use to topical applications or environmental sterilization (PubChem, CID 713).
Non-specific disruption of bacterial cellular integrity through oxidation, protein denaturation, and covalent modification of nucleic acids and lipids.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple bacterial macromolecules.